Optimization of current and future therapy for autoimmune diseases.
Department of Neurology and Neurological Sciences, Stanford University, Stanford, California, USA. steinman@stanford.edu
Lawrence
L
Steinman
Joan T
JT
Merrill
Iain B
IB
McInnes
Mark
M
Peakman
D000941:Antigens / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy*; D054316:Biomarkers, Pharmacological; D004338:Drug Combinations; D006801:Humans; D016899:Interferon-beta / Q000235:genetics / Q000627:therapeutic use; D058990:Molecular Targeted Therapy; D015398:Signal Transduction; D057170:Translational Research, Biomedical; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000378:metabolism
D000941:Antigens; D054316:Biomarkers, Pharmacological; D004338:Drug Combinations; C439524:TNF protein, human; D014409:Tumor Necrosis Factor-alpha; D016899:Interferon-beta